Patent · US Active

Proteolytic enzyme formulations

US8632769B2 · kind B2 · utility

5Cited by
2References
7Claims
0Family size

Inventor

Key dates

Filing dateAug 30, 2012
Grant dateJan 21, 2014
Priority date—
Expiry dateAug 30, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Preferred embodiments of the present invention relate to proteolytic enzyme formulations. More specifically, several embodiments relate to a proteolytic formulation to facilitate digestion, metabolism, degradation of target compounds, and systemic enzymatic action. Embodiments for improving oxygenation and reducing plaque are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.